MG Biotherapeutics LLC · Minneapolis, MN United States
| 710 Medtronic Pkwy. | Phone: 763-514-4000 |
| Minneapolis, MN | Fax: 763-514-4879 |
| 55432 | |
| United States | 
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowMG Biotherapeutics LLC Rankings
Company Description
Genzyme and Medtronic are out to prove that it doesn't just take time to heal a broken heart. The two companies' joint venture, MG Biotherapeutics, was created in 2004 to develop new treatments for heart attacks and other cardiovascular conditions. The venture conducts biotechnology research and development programs, including programs seeking to use cellular grafting therapies to repair damaged heart tissue. MG Biotherapeutics is also engaged in the development of a less-invasive, catheter-based delivery system for cell-based therapies using Medtronic's technologies.
MG Biotherapeutics LLC Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Joint VentureSingle Location |
|---|
| Fiscal Year-End | December |
|---|
| Employees | 50 |
|---|
Top MG Biotherapeutics LLC Competitors
More Companies in These Related Industries: Pharmaceutical Preparation Mfg